Cargando…
Striving toward hyperthermia-free analgesia: lessons from loss-of-function mutations of human TRPV1
Transient receptor potential vanilloid 1 (TRPV1), a receptor for capsaicin and noxious heat, has been one of the most compelling targets for analgesics. However, systemic inhibition of TRPV1 is an impractical approach as a pain killer, since systemic antagonism induces hyperthermia. Two articles in...
Autores principales: | Li, Tingting, Chung, Man-Kyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888373/ https://www.ncbi.nlm.nih.gov/pubmed/36719371 http://dx.doi.org/10.1172/JCI167338 |
Ejemplares similares
-
Polypeptide Modulators of TRPV1 Produce Analgesia without Hyperthermia
por: Andreev, Yaroslav A., et al.
Publicado: (2013) -
Striving toward excellence
por: Mittal, BR
Publicado: (2014) -
Ablation of TRPV1+ Afferent Terminals by Capsaicin Mediates Long-Lasting Analgesia for Trigeminal Neuropathic Pain
por: Wang, Sheng, et al.
Publicado: (2020) -
‘Functional hyperthermia’: a historical overview
por: Ginier-Gillet, Mathieu
Publicado: (2023) -
Striving for better health through health research in post-conflict Timor-Leste
por: Martins, Nelson, et al.
Publicado: (2012)